Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$0.94 - $1.89 $41,924 - $84,295
-44,601 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$1.5 - $9.38 $9,139 - $57,152
-6,093 Reduced 12.02%
44,601 $80,000
Q2 2020

Aug 05, 2020

SELL
$4.79 - $8.39 $98,908 - $173,245
-20,649 Reduced 28.94%
50,694 $425,000
Q1 2020

May 14, 2020

SELL
$3.44 - $7.21 $35,803 - $75,041
-10,408 Reduced 12.73%
71,343 $374,000
Q4 2019

Feb 13, 2020

BUY
$4.29 - $5.64 $192,492 - $253,066
44,870 Added 121.66%
81,751 $446,000
Q3 2019

Nov 12, 2019

SELL
$4.87 - $7.08 $10,002 - $14,542
-2,054 Reduced 5.28%
36,881 $180,000
Q2 2019

Aug 13, 2019

SELL
$6.6 - $7.8 $11,173 - $13,205
-1,693 Reduced 4.17%
38,935 $270,000
Q1 2019

May 14, 2019

SELL
$5.76 - $8.95 $31,789 - $49,395
-5,519 Reduced 11.96%
40,628 $282,000
Q4 2018

Feb 05, 2019

SELL
$5.26 - $7.97 $164,538 - $249,309
-31,281 Reduced 40.4%
46,147 $269,000
Q3 2018

Nov 14, 2018

SELL
$4.65 - $7.95 $257,898 - $440,922
-55,462 Reduced 41.74%
77,428 $585,000
Q2 2018

Aug 10, 2018

BUY
$5.05 - $6.8 $153,504 - $206,699
30,397 Added 29.66%
132,890 $671,000
Q1 2018

May 14, 2018

BUY
$5.6 - $9.25 $308,375 - $509,369
55,067 Added 116.11%
102,493 $625,000
Q4 2017

Feb 14, 2018

SELL
$6.6 - $7.78 $55,987 - $65,997
-8,483 Reduced 15.17%
47,426 $337,000
Q3 2017

Nov 14, 2017

BUY
$5.75 - $7.75 $29,405 - $39,633
5,114 Added 10.07%
55,909 $400,000
Q2 2017

Aug 14, 2017

BUY
N/A
50,795
50,795 $320,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.63B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.